A comprehensive view of Quest Diagnostics Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Americares and Quest Diagnostics partner to provide free diagnostic services and expanded telehealth support to address health disparities in underserved communities; ten clinics get free diagnostic services, other clinics in get telehealth grants
Published: September 13, 2023 by M2 PressWIRE
Quest Diagnostics releases its 2022 Corporate Responsibility Report; in 2022, Quest discounted or donated 750,000 test requisitions through its patient assistance programs and the company received its ISO14001 environmental management certification
Published: September 07, 2023 by PR Newswire
Quest Diagnostics Foundation grant allows Rutgers University's H.O.P.E. Clinic to provide no-cost lab tests and primary care services on two days per week instead of one; tests offered for diabetes, hypertension, STDs and Lyme disease
Published: September 06, 2023 by Rutgers University
Quest Diagnostics granted FDA Breakthrough designation for its AAVrh74 ELISA assay edeno-associated virus test; test identifies patients eligible for treatment with Sarepta Therapeutics' ELEVIDYS gene therapy for Duchenne muscular dystrophy
Published: August 30, 2023 by PR Newswire
Quest Diagnostics declares quarterly cash dividend of US$0.71 per share, payable on October 23, 2023 to shareholders of record of Quest Diagnostics common stock on October 6, 2023
Published: August 15, 2023 by Quest Diagnostics Inc.

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count